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ABSTRACT
Acetaminophen (APAP)-induced liver injury is clinically significant, and APAP overdose in mice often serves as a model for
drug-induced liver injury in humans. By specifying that APAP metabolism, reactive metabolite formation, glutathione
depletion, and mitigation of mitochondrial damage within individual hepatocytes are functions of intralobular location, an
earlier virtual model mechanism provided the first concrete multiattribute explanation for how and why early necrosis
occurs close to the central vein (CV). However, two characteristic features could not be simulated consistently: necrosis
occurring first adjacent to the CV, and subsequent necrosis occurring primarily adjacent to hepatocytes that have already
initiated necrosis. We sought parsimonious model mechanism enhancements that would manage spatiotemporal
heterogeneity sufficiently to enable meeting two new target attributes and conducted virtual experiments to explore different
ideas for model mechanism improvement at intrahepatocyte and multihepatocyte levels. For the latter, evidence supports
intercellular communication via exosomes, gap junctions, and connexin hemichannels playing essential roles in the toxic
effects of chemicals, including facilitating or counteracting cell death processes. Logic requiring hepatocytes to obtain current
information about whether downstream and lateral neighbors have triggered necrosis enabled virtual hepatocytes to achieve
both new target attributes. A virtual hepatocyte that is glutathione-depleted uses that information to determine if it will
initiate necrosis. When a less-stressed hepatocyte is flanked by at least two neighbors that have triggered necrosis, it too will
initiate necrosis. We hypothesize that the resulting intercellular communication-enabled model mechanism is analogous to
the actual explanation for APAP-induced hepatotoxicity at comparable levels of granularity.
Key words: drug-induced liver injury; hepatic zonation; model mechanism; simulation; systems modeling; virtual
experiment.
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Acetaminophen (APAP) within its therapeutic range is safe but can
produce pericentral (PC) hepatic necrosis in humans and animals
when overdosed. To better understand and explain the causes and
consequences, it has been studied for decades as a model hepato-
toxicant in animals. A characteristic early feature in mice is that
necrosis, preceded by covalent adduct formation, begins adja-
cent to the central vein (CV) and progresses periportally.
A long-standing explanation for the zonation of necrosis in
APAP hepatotoxicity is that increasing periportal (PP) to PC pro-
duction of NAPQI (N-acetyl-p-benzoquinone imine) is sufficient
to explain early PC necrosis. Challenging that explanation in
mice is impracticable. Smith et al. (2016) endeavored to circum-
vent the challenges of the in vivo mouse model by developing
and experimenting on model mechanisms of APAP-induced
hepatotoxicity within virtual mice. One, named the NZ-
Mechanism, is a parsimonious, somewhat coarse grain instanti-
ation of the NAPQI zonation theory. Measurements of APAP he-
patic disposition and metabolism recorded during execution are
quantitatively and qualitatively similar (biomimetic) to reported
observations within and across several biological levels. Despite
substantial zonation of NAPQI production, average early trigger-
ing of necrosis occurred first PP and not PC. The results provide
strong evidence that NAPQI zonation alone is insufficient to ex-
plain early PC necrosis. A somewhat finer grain explanation
would be required to cause early PC necrosis.
Starting with the NZ-Mechanism, we created two new model
mechanisms by inscribing zonation of one additional feature in
each. The GNZ-Mechanism specified that GSH Depletion
Threshold values decrease PP to PC. The MNZ-Mechanism speci-
fied that a virtual hepatocyte’s ability to mitigate the (mitochon-
drial) damage that triggers necrosis diminishes PP to PC. Results
of experiments employing those Mechanisms showed that, early
triggering of necrosis was shifted toward the CV, but not suffi-
ciently. The average early location was midzonal and not PC.
However, when the two mechanisms were merged to form the
MGNZ-Mechanism, average early triggering of necrosis occurred
PC. We argued that, at corresponding degrees of granularity, the
essential features of the MGNZ-Mechanism and the actual APAP-
induced hepatotoxicity mechanism in mice may be strongly anal-
ogous within and across multiple lobular levels (Smith et al., 2016).
Experiments using the MGNZ-Mechanism focused on im-
proving a mechanism-based explanation for early features of
APAP-induced hepatotoxicity and employed prespecified quali-
tative and quantitative target attributes. However, if we make
the criteria for achieving a target attribute more stringent, the
MGNZ-Mechanism may no longer be adequate—it would be fal-
sified. Re-engineering would then be needed to achieve the re-
vised set of targeted attributes. Consider imposing two new
target attributes: (1) the earliest necrosis trigger events must oc-
cur first adjacent to CV, and (2) subsequent early necrosis trigger
events must occur primarily adjacent to virtual hepatocytes
(vHPCs) that have already triggered necrosis. The new target
attributes help falsify the MGNZ-Mechanism. Virtual experi-
ments employing the MGNZ-Mechanism exhibited few early ne-
crosis trigger events directly adjacent to CV, and many early
trigger events were isolated from each other, dispersed among
other virtual hepatocytes in a heterogeneous pattern.
The objective of this research is to impose the above two
more stringent attributes as simulation targets and seek reason-
ably parsimonious enhancements to the MGNZ-Mechanism—
Control mechanism hereafter—that would enable meeting
both. The search for plausible improvements could begin at ei-
ther the intracellular level or the cell behavior level. We explore
both but focus on the latter motivated by two considerations. (1)
Evidence supports that intercellular communication via exo-
somes (Hirsova et al., 2016), gap junctions (Asamoto et al., 2004;
Decrock, et al., 2009), and connexin hemichannels (Maes et al.,
2017) plays various roles in determining toxic effects of chemi-
cals, facilitating or counteracting the cell death process. (2) The
mechanism and software re-engineering required to add
communication-enabled rule-based capabilities to the Control
mechanism were expected to be modest.
We discovered a pair of rules that require knowledge of
whether a downstream or lateral neighbor has triggered necro-
sis to determine whether a stressed virtual hepatocyte triggers
necrosis. We present the results of virtual experiments in which
virtual mice (Figure 1) employed a modified version of the
Control mechanism (Figure 2) and utilized that pair of rules to
achieve both new target attributes. We hypothesize that the
resulting intercellular communication-enabled model mecha-
nism is analogous to the actual explanation for APAP-induced
hepatotoxicity at comparable levels of granularity.
MATERIALS ANDMETHODS
We experiment on two kinds of virtual Mice. Control Mice uti-
lize previously validated spatiotemporal model mechanisms
(see Requirements) that simulate characteristic early features of
APAP hepatotoxicity (Smith et al., 2016). Virtual hepatocytes
within Control Mice are quasi-autonomous agents; they do not
communicate with neighboring vHPCs. The objective for this
work was to discover a reasonably parsimonious set of mecha-
nism enhancements that would enable APAP-induced necrosis
in Test Mice to always occur first adjacent to the CV and then
spread outward in the PP direction, while continuing to achieve
the original Similarity Criteria. To limit confusion hereafter and
distinguish virtual Mouse components, characteristics, and
phenomena from real mouse counterparts, we capitalize the
former and, in some cases, append the prefix v to the object’s
name. Names of model mechanism features and specifications
(parameters) are italicized.
Technical Details
The Java-based MASON multiagent toolkit framework serves as
the basis for virtual Mice and many of the model mechanism
components (Luke et al., 2005). In earlier work, we referred to
virtual Mice as Mouse Analogs (Liver Analogs, Hepatocyte
Analogs, etc.) to stress the fact that model mechanism entities
(Hunt et al., 2018) are intended to be strongly analogous to their
biological counterparts, yet not to model the biology precisely.
We utilize agent-oriented modeling methods and techniques
(Hunt et al., 2013; Macal and North, 2010). Agent-oriented model-
ing methods allow for complex software entities (agents) which
can implement their own rules and schedules, and which there-
fore can be made biomimetic in multiple ways. Hunt et al. (2018)
characterize the spectrum of mechanism-oriented model types
being used to help explain biological phenomena. They distin-
guish three broad types: mechanistic explanation, an analogous
mechanism model, and a model mechanism. This work is an
example of the latter. We use agent-oriented methods and com-
ponents to make the model mechanisms utilized by Control
and Test Mice concrete and biomimetic. Consequently, map-
pings exist between the model mechanism’s discrete entities
and activities, as well as biological counterparts. The expecta-
tion is that measurements of a phenomenon generated during
execution of a computational model mechanism would ade-
quately match measurements of the actual target phenomenon,
within some tolerance, qualitatively and quantitatively.
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We refer to one execution of virtual Mouse software as a trial
simulation (simply trial, hereafter). Most events occurring dur-
ing a trial are stochastic. Numbers of several entities and values
Figure 1. Virtual Mouse components and their organization. A, A virtual Mouse
comprises a Liver, Mouse Body, as well as a space to contain Dose for simulating
intraperitoneal dosing. B, An illustration of a sectioned hepatic lobule. Different
shading illustrates idealized zonation. C, An illustration of a portion (only 16%)
of one Monte Carlo-sampled Lobule. D, One Sinusoid Segment (SS) maps to a
portion of a lobule, within one of the three illustrated Layers. E, An illustration
of a multi-layered SS. F, Virtual Cell objects occupy 99% of the Endothelial Cell
space and all of the Hepatocyte space.
Figure 2. Intrahepatocyte events initiated by APAP. A, Within Control Mouse
vHPCs, these events and activities may execute each simulation cycle. They do
so independently in a pseudo-random order. Events marked with an asterisk
are stochastic. Right side check marks designate features that are subject to
Zonation. B, These five graphs show how particular features depend on
Lobular location. Left side: the value assigned to vHPCs adjacent to the Portal
Vein (PV) entrance. Right side: the value assigned to vHPCs adjacent to the
central vein (CV). C, Within Test Mouse vHPCs, the Stressed and Necrosis-
Triggered features replace Necrosis-Triggered in Control Mice. Initiation of
Necrosis-Triggered is changed to initiation of Stressed (the Threshold value is
unchanged). Information about the status of neighbors is used to determine
when Necrosis-Triggered may be initiated. Damage mitigation and all other
upstream features are unchanged from A.
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governing the occurrence of specific activities are Monte Carlo
sampled during the simulation, ie, the specific value for that
trial is determined by a (pseudo) random draw from a prespeci-
fied distribution. Probabilities governing most stochastic events
are stated in the specifications. The probability assigned to each
stochastic event in Figures 2A and 2B was arrived at during
Iterative Refinement (IR) Protocol cycles (described below) as de-
tailed previously (Smith et al., 2014, 2016). The default probabil-
ity value is .5. It is used for any stochastic event for which the
wet-lab evidence is insufficient or too uncertain to guide or jus-
tify selecting a different value. We continue using a default
probability until a model mechanism failure forces a change.
Most phenomena generated by Control and Test Mice are
relatively insensitive to moderate changes to any one event
probability value. However, moderate changes to several event
probability values can cause noticeable changes in one or more
generated phenomena.
The R programming language was used to facilitate analysis
and to plot experiment measurements. Virtual Mice and specifi-
cation files are managed using the Subversion version control
tool in two repositories, one private (Assembla) and another
public. All specification values for Control vHPCs are the same
as used previously by Smith et al. (2018). Values for crucial
Control and Test vHPC specifications are listed in
Supplementary Table 1. Our entire toolchain is open source.
The data presented herein along with the code are available
from project websites (https://simtk.org/projects/aili; last
accessed February 19, 2019 and https://simtk.org/home/isl/; last
accessed February 19, 2019).
Histology
Male WT C57Bl/6J mice were purchased from the Jackson
Laboratory (Bar Harbor, Maine). The mice were used for experi-
ments at 8–12 weeks of age. Animals were housed in a
temperature-controlled facility with a 12 h light/dark cycle and
allowed ad libitum access to food and water. Food was with-
drawn 12–16 h before treatment with 300 mg/kg APAP. APAP
was dissolved in warm 1 phosphate-buffered saline and
injected i.p. Liver tissue was harvested at 0, 1, 2, 3, 4.5, and 6 h
post-APAP. A piece of each liver was fixed in 10% phosphate-
buffered formalin and then embedded in paraffin wax. Sections
(5mm thick) from each liver were stained with hematoxylin and
eosin (H&E) for histology. Additional sections were stained for
DNA fragmentation using a terminal deoxynucleotidyl transfer-
ase dUTP nick-end labeling (TUNEL) kit from Roche
(Indianapolis, Indiana), as described previously (Gujral et al.,
2002). All animal protocols were approved by the Institutional
Review Boards or the University of Kansas Medical Center and
the University of Arkansas for Medical Sciences.
Virtual Mice: Structure and Function
Figure 1 illustrates a virtual Mouse, which consists of a Body, a
Liver, and a space for the virtual acetaminophen (vAPAP) dose.
We developed the Liver using an IR Protocol (discussed below)
and by adhering to strong parsimony guideline: resist adding
plausibly more realistic detail until it is needed to achieve a par-
ticular attribute or validation target. During each trial, phenom-
ena generated are qualitatively and quantitatively analogous to
actual wet-lab counterparts across several metrics. It met target
attributes in six studies (Park et al., 2009, 2010; Smith et al.,
2014, 2016; Yan et al., 2008a,b). The Liver has a specified number
of Monte Carlo-determined Lobule variants. One Lobule maps to
a small random sample of possible lobular flow paths within a
whole liver, and reflects the fact that APAP in blood entering
portal vein (PV) tracts gets exposed to many more hepatocytes
than does APAP in blood exiting the CV. A virtual Lobule (Figure
1C) is a directed graph with a Sinusoidal Segment (SS) agent at
each node. Flow follows the directed graph. We organize graph
nodes into three Layers, which map to three lobular zones.
There are 45 nodes in Layer 1, 20 in Layer 2, and 3 in the third
Layer. That structure maps directly to the quasi-polyhedral na-
ture of hepatic lobules. In Control Livers, all SS dimensions are
Monte Carlo determined within constraints that enabled
achieving previously described Target Attributes. SS dimensions
in Layers 1 and 2 are Monte Carlo determined as in Control
Livers. However, the circumferences of all Layer 3 SSes are 30
grid spaces and the lengths are 8 grid spaces.
The 45/20/3 ratio of directed graph nodes in Layers 1–3 does
not represent relative amounts of tissue in 3 acinar zones. The
number and arrangement of graph nodes along with SS dimen-
sions came from challenging various graph topologies using the
IR Protocol (below). That arrangementprovided the variety of flow
paths needed to achieve quantitative liver perfusion and hepatic
disposition validation targets for several drugs in normal and dis-
eased rat livers (Hunt et al., 2006; Park et al., 2009; Yan et al.,
2008a,b); it maps adequately to relative lobular volumes. There is
a chance that some virtual experiment results may change in
subtle ways if small changes are made to graph topology.
However, our sensitivity studies have not shown such changes.
A SS comprises a Core, Blood-Cell Interface, Endothelial Cell
Space, Space of Disse, Hepatocyte Space, and Bile (not a factor
for this work). Events occurring within a particular SS are
strongly analogous to referent events within portions of sinus-
oids and adjacent tissue. vAPAP, its Metabolites, and other vir-
tual Compounds (vCompounds) are mobile objects. A vAPAP
maps to a tiny fraction of an APAP Dose, which for these experi-
ments is 45 000 objects. Mobile objects from Mouse Body are
first delivered to the PV. Extra-Cellular mobile objects percolate
stochastically through accessible spaces toward the CV influ-
enced by specifications that control local flow. Mobile objects
exit a Layer 3 SS into the CV and then get moved to the Body.
PV-to-CV gradients provide intra-Lobular location information
to each vHPC.
Each Cell is a software agent. Cells in Endothelial space con-
trol vAPAP entry and exit and contain a probability-specified
number of Binders; they merely bind and release vAPAP and
map to a conflation of all epithelial cell components responsible
for nonspecific vAPAP binding.
Control Mice: Intrahepatocyte Model Mechanisms
vHPCs within a Control Mouse Liver utilize the Control mecha-
nism illustrated in Figures 2A and 2B. Entry and exit of mobile
objects from each Endothelial Cell and vHPC are mediated by
the Cell, according to the vCompound’s properties. On average,
there are 16 165 vHPCs per Lobule. Objects within vHPCs and
their capabilities are identical to those used previously (Smith
et al., 2016). The event descriptions that follow are per simula-
tion cycle. vHPCs contain four types of physiomimetic event
management modules (Petersen et al., 2014) to control material
entry and removal along with binding and the object transfor-
mations described in Figure 2: MetabolismHandler,
BindingHandler, InductionHandler, and EliminationHandler (the last
two are not used in this work). The order of events is (pseudo)
randomized during each simulation cycle.
There is a direct mapping between the probability of a
vAPAP Metabolism event and the amount of metabolic
enzymes. The probability of a vAPAP Metabolic event and the
probability that the Metabolite is NAPQI each increase 3-fold
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from PV entrance to CV. All other metabolites are lumped to-
gether and divided equally between G (maps to APAP glucuro-
nide) and S (maps to the APAP sulfate metabolite). Each of the 5
gradients in Figure 2B is implemented explicitly as a function of
distance from PV entrance to the vHPC’s position. Each vHPC
uses a location-dependent value drawn from those gradients.
We represent the futile cycle in which APAP is deacetylated to
para-aminophenol followed by rapid reacetylation back to
APAP, even though the cycle has been viewed as having little
importance in APAP-induced hepatotoxicity in humans and
mice (Miyakawa et al., 2015).
The probability during each simulation cycle that a NAPQI is
removed (maps to undergoing a reaction) is .5. Each vHPC is
assigned a location-dependent value for its GSH Depletion
Threshold. Before the Threshold is breached, and once a NAPQI
is created, it is eliminated 90% of the time, and the GSH
Depletion accumulator is incremented by 1.0, which maps to
depleting a fraction of a hepatocyte’s available GSH. However,
10% of the time, the NAPQI object remains in the vHPC. The
Threshold is breached when the accumulator value exceeds the
vHPC’s GSH Depletion Threshold value, which maps to GSH de-
pletion. In each cycle, there is a 50% chance that a NAPQI object
will be removed and that one of the two types of Damage prod-
uct will be added to that vHPC: a mitoD object maps to a confla-
tion of a fraction of all mitochondrial damage products; a
nonMD object maps to a conflation of a fraction of all other
types of damage products. The granularity of mitoD in the
above process proved to be insufficient to simulate downstream
toxicity events. Mindful of our strong parsimony guideline, we
amplify mitoD formation: we specify that one NAPQI ! (1þn)
mitoD. Without wet-lab data for guidance, we specified n to be a
pseudo-random draw from a Gaussian distribution with x¼ 4,
SD¼ 1. Such mitoD amplification can also map to the accumula-
tion of reactive oxygen/nitrogen species.
We assume that hepatocyte death always follows triggering
of necrosis. Once the amount of accumulated mitoD exceeds
the Necrosis Threshold, the Necrosis-Triggered state is induced.
Further, because necrosis is a process, there is a delay between
the triggering event and when necrosis becomes detectable in
stained tissue sections. Within Control and Test Mice, for each
vHPC, that delay interval is a pseudo-random draw from a uni-
form distribution [Max, Min] that is specified by
necrosisDelay[Max, Min]. There is considerable uncertainty about
the timings of triggering events and histological confirmation of
necrosis. And there is no evidence of necrosis occurring by 1 h.
Smith et al. (2016) use Min¼ 1.2 h (4320 simulation cycles) and
Max¼ 12 h (43200 cycles). For simplicity and clarity of results,
we use Min¼ 1.39 h (5000 cycles) and Max¼ 5001 cycles.
In vivo hepatocytes utilize multiple mechanisms to mitigate
or reverse damage. Consistent with our parsimony guideline,
we implemented a single mitigation mechanism, repurposing a
Metabolism Module, and named it Damage Mitigation. It maps
to a conflation of all actual mitigation/recovery/macromolecu-
lar repair mechanisms, including removal of acetaminophen-
protein adducts by autophagy (Ni et al., 2016). With a location-
specified probability, a Repair object replaces a Damage prod-
uct. We focused on mitoD because only its biological counter-
part can trigger Necrosis. Specifying that the probability of a
mitoD Mitigation event decreases sigmoidally PV-to-CV en-
abled Necrosis-Triggered events to occur first close to—but not
at—the CV in the Control mechanism, as documented in
Results, and is consistent with the observation that zonated
induction of autophagy limits APAP-induced necrosis (Ni et al.,
2013).
Requirements
To achieve the objective, we utilize the virtual experiment pro-
tocol outlined by Kirschner et al. (2014), as updated by Smith
et al. (2016) and Petersen and Hunt (2016). We adapted this defi-
nition of a mechanism from Darden (2008) and Illari and
Williamson (2012) as applied to generation of a biological phe-
nomenon: entities and activities organized and orchestrated in
such a way that they are responsible for the phenomenon to be
explained. All features of Control and Test model mechanisms
during operation meet that definition. Thus, Control and Test
model mechanisms are concrete hypotheses for how features of
APAP hepatotoxicity in mice are generated. Five requirements
are specified to guide software engineering, mechanism instan-
tiation, and simulation refinements. (1) Virtual entities are con-
crete and biomimetic in prespecified ways. (2) Model
mechanism features during each trial are measurable. (3)
Specific feature measurements match or mimic (ie, are strongly
analogous to) prespecified Targeted Attributes, but only to the
extent needed to achieve the Similarity Criteria. (4) Higher-level
phenomena arise during each trial from concrete component
interactions at a lower level. (5) Present arguments that, during
each trial, at a comparable level of granularity, the model mech-
anism has a biological counterpart.
Limits on Mappings
Lobules are not designed to map directly to hepatic lobules and
a SS does not map directly to a portion of a single sinusoid sur-
rounded by hepatic endothelial cells and hepatocytes. Instead,
a Lobule maps to a small random sample of possible lobular
flow paths within a whole liver. The mapping from cylindrical
2D Hepatocyte Space to corresponding 3D configurations of
hepatocytes is indirect and not intended to be literal. Instead,
for its function as a component of a model mechanism, it is
intended to be adequately analogous. We sought a balance be-
tween the computation programmed into the objects and their
methods. Lobule design does enable measurements of the
Hepatic Disposition and Metabolism of vCompounds during vir-
tual Liver perfusion experiments—averaged over many Monte
Carlo trials—to validate quantitatively to temporal measure-
ments of referent compounds made during liver perfusion
experiments.
Iterative Refinement Protocol
Starting with a verified copy of Control Mouse code, achieving
the objective required making and testing incremental changes
to model mechanism features and their specifications. Each
step of the process followed a version of the IR Protocol (Hunt
et al., 2009), which is a best practice for developing scientifically
useful model mechanisms (Petersen et al., 2016; Smith et al.,
2016). Each execution generates predictions that are tested or
challenged during an IR Protocol cycle. The goal of an IR
Protocol cycle is to test whether, during each trial, a simulation
feature will mimic a target attribute at a specified tolerance.
Failure to do so falsifies the current model mechanism.
Overcoming such failures improves explanatory insight and
credibility. There are six key IR Protocol cycle steps. (1) State the
cycle’s objective. (2) Specify Target Attributes and Similarity
Criteria. (3) Specify granularity for the updated model mecha-
nism. (4) Revise mechanism in small steps, while adhering to a
strong parsimony guideline. Record reasoning for modifica-
tions, and create a revision plan. (5) Evaluate the results of vir-
tual experiments designed to evaluate revisions; and (6)
Determine if Target Attributes have been achieved. If not, offer
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a plausible explanation and corrective strategy, and start a new
IR Protocol cycle.
Building the Credibility of Virtual Mice
Test mice are works in progress. They are a stage in the larger ef-
fort of developing improved models of explanation for features
of APAP-induced hepatotoxicity. The virtual experiments de-
scribed herein provide an explicit way of incrementally con-
necting (or not) a putative explanatory model mechanism to a
phenomenon of interest. During each stage, validation, falsifica-
tion, verification, and prediction efforts contribute differently to
building the credibility of evolving mechanism-based
explanations.
Prediction. In science, explanations are usually inductive. Ideally,
explanation precedes prediction, permitting deductive reason-
ing (Mulugeta et al., 2018). Each virtual Mouse execution gener-
ates predictions, some of which are selected for testing during
the next IR Protocol cycle. However, the focus is on improving
the mechanism-based explanation. When needed or justified, it
is straightforward to use the tuneable resolution approach
(Kirschner et al., 2014) to add details that improves apparent re-
alism (eg, see Pogson et al., 2006). However, we aim to keep
Control and Test Mouse mechanisms parsimonious in order to
retain scientific usefulness. As explanatory credibility increases,
an additional effort can be invested in achieving more precise
predictions of hepatotoxicity features.
Validation and falsification. Virtual Mice are both structural and
behavioral hypotheses for corresponding mouse experiment
features. The phenomena generated and the events occurring
during an execution are features of a concretized mechanism-
based explanatory hypothesis. As such, validation methods in-
clude both explanatory and predictive types, and are both quali-
tative and quantitative. Because Test Mice are instantiated
hypotheses, failed IR Protocol cycles indicate a flawed aspect of
the instantiated hypothesis. Successive IR Protocol cycles aim
to overcome that failure. Thus, in advancing the science, valida-
tion is just one part of an ongoing two-part process.
Falsification is the essential second part. Increasing Similarity
Criteria or adding new Target Attributes (as done here) can fal-
sify a model mechanism. We demonstrate herein that an essen-
tial part of increasing credibility is planning the falsification of
the current best explanation. Protocols for mechanism hypothe-
sis testing are those used previously (Smith et al., 2014, 2016).
They involve pairing a qualitative or quantitative measurement
with well-defined Similarity Criteria. Each pairing requires con-
sideration of two aspects of the Target Attribute: (1) similarity
between measurements of a Test Mouse’s phenomenon and
measurements of the corresponding wet-lab phenomenon, and
(2) similarity of variability within and between repeat virtual
and wet-lab measurements. Because events occurring during
an execution are concretized, specific events and features can
be singled out as potential future validation targets (but other-
wise may not be recognized as such).
Verification. Using pseudo-random generators facilitates verifica-
tion. Because virtual Mice constitute concrete structural mecha-
nism hypotheses, verification is most straightforward for
mathematically well-defined subcomponent requirements.
Unit tests for those use cases are included side by side with the
components in the repositories. Integrated verification is per-
formed traces, self-consistency, and face validation with the
comparison of the expected against the measured systemic im-
pact of a new or modified component.
Two Divergent Approaches
We imposed two additional target attributes: the earliest
Necrosis-Triggered events occur first adjacent to the CV, and
subsequent Necrosis-Triggered events occur primarily adjacent
to vHPCs that have already Triggered Necrosis. There is a spec-
trum of Control mechanism variants that can be used to begin
achieving both new target attributes plus those already
achieved. We began at the parsimonious end of the spectrum
and explored two divergent approaches: (1) keep vHPCs quasi-
autonomous and focus on making intra-vHPC events (Figure 2)
incrementally more interconnected and detailed, consistent
with available evidence. (2) Alternatively, in Test Mice, empha-
size inter-vHPC communication and acquisition of neighbor sta-
tus information. Hepatic reality likely involves both, but the IR
Protocol stresses an incremental approach in which we resist
adding plausibly more realistic detail until it needs to achieve a
particular attribute or validation target. We limit attention to
the first 6 h following the vAPAP dose and do not consider
enhancements that require time-dependent Mechanism
changes, such as Enzyme induction (Ropella et al., 2009), al-
though such enhancements are expected to become necessary
as we begin explaining additional phenomena beyond 6 h. For
example, evidence indicates that, as stress declines pericen-
trally 6–12 h post-dose, adaptive responses to cellular stress, in-
cluding mitophagy and mitochondrial biogenesis, become
increasingly influential (Du et al., 2017; Ni et al., 2013).
The approach for option (2) is presented in the next subsec-
tion. For option (1) we considered several refinements of partic-
ular events in Figure 2A. To merit exploration, we required
preliminary evidence that a refinement would skew Necrosis-
Triggered events toward the CV. One was successful, and it in-
volved linking mitoD amplification and the GSH Depletion
Threshold. Within Control Mice, mitoD amplification is inde-
pendent of location and the number of GSH Depletion events.
We specified that breaching the GSH Depletion Threshold be a
requisite for mitoD amplification. Doing so makes mitoD ampli-
fication location dependent. An option for future consideration
is upregulation of Damage Mitigation triggered by accumulating
a minimum amount of Damage. The current coarse grain
Damage Mitigation events subsume fine grain subprocesses
such as mitophagy and mitochondrial biogenesis.
Acquiring and Using Information About Neighbors
Despite the above mapping limitations, we reasoned that en-
hancing the Control model mechanism by requiring an ex-
change of information among neighboring vHPCs within the
same SS could serve as biomimetic analogies of in vivo counter-
parts. Our initial premise was that information provided
through interhepatocyte communication is necessary for estab-
lishing the characteristic spatial patterns of APAP-induced ne-
crosis. We assumed that information exchange among
neighboring hepatocytes is a continuous process, and specu-
lated that so long as a hepatocyte is capable of recovering from
toxin-induced injuries, communication continues.
We specified that a vHPC could obtain information only
about neighbors residing in a predefined Moore or von
Neumann neighborhood. We posed this question: without
changing the pre-Necrosis Trigger model mechanisms in Figure
2A, can we discover a plausible combination of rules that each
vHPC must follow, and in doing so, can we achieve our objec-
tive, ie, Necrosis-Triggered in Test Mice always occurs first
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adjacent to CV and then spreads in the PP direction? If doing so
is problematic, that would falsify one or more features of the
Figure 2A model mechanisms. By achieving our objective, we
can argue that analogous processes may occur in vivo. Further, a
discovery of such logic would provide a fresh mechanism-
oriented perspective for improving explanations of patterns of
APAP-induced hepatic injury.
We conjectured that hepatocytes in vivo that are close to the
CV, especially those adjacent to the CV, are aware of their
unique location. To provide Test vHPCs with similar informa-
tion, we added the new Adjacency feature to each vHPC.
Specifying Adjacency¼ 0 means the vHPC is directly adjacent to
the CV. The adjacency information is needed to step through
the logic (described in Results). Upon execution, each vHPC
queries its SS grid to establish its location. Each SS grid point is
defined by an x- (circumference within grid) and y-value (direc-
tion of flow). A particular vHPC identifies the location of its
neighbors by comparing a neighbor’s y- and x-values to its own.
During each simulation cycle, each member of the neighbor-
hood is queried for its status.
For early IR Protocol cycles, we relied on MASON’s built-in
methods for all neighborhood calculations, including the toroi-
dal method that wraps each SS 2D grid to mimic a cylinder.
However, wrapping appeared to go beyond the origin, and that
caused extraneous neighbors counting downstream von
Neumann or Moore neighbors. To avoid that problem, we added
logic to specify when wrapping is allowed during that determi-
nation. Doing so enabled us to count downstream neighbors
more explicitly.
Pericentral Snapshot Animations
We implemented an SS visualization method, hereafter PC
Animations. Studying PC Animations facilitates evaluating spa-
tiotemporal changes in vHPC status—Normal, Stressed,
Necrosis-Triggered, and Necrotic—among Layer 3 SSes, and aids
verification following each implementation change. During
each trial, at the end of each simulation cycle, if one or more
vHPCs changed status during that simulation cycle, then a
snapshot was recorded and time-stamped. It identified the sta-
tus of all vHPCs in the SS at the end of that cycle. We strung to-
gether in sequence all the snapshots from each Layer 3 SS
during one trial into a single animation. Observing location-
specific temporal changes in status enabled us to identify po-
tentially nonbiomimetic features, and gauge progress.
Measurements
Virtual measurements are made analogous to wet-lab counter-
parts to facilitate comparisons when wet-lab data are available.
Data are measurements of selected vAPAP Disposition,
Metabolism, and Toxicity-related phenomena. Because each tri-
al’s specification is Monte Carlo determined and the unfolding
of events is stochastic, there is considerable variability among
measurements from multiple trials governed by the same set of
initial specification values. Consequently, results from a single
experiment require aggregating measurements across several
trials, for which we use the average. For this work, one
experiment¼ 12 Monte Carlo trials. During each trial, each dis-
crete simulation cycle maps to approximately 1 s. In some
cases, we measured selected phenomena for each Monte Carlo
trial.
During each experiment, for each vHPC, we measured
amounts of vAPAP, NAPQI, and mitoD, along with counts of the
following events: GSH Depletion, Damage Mitigation, plus initi-
ation of Stressed, Necrosis-Triggered, and Necrotic. They were
then summed or averaged for the entire Lobule and within two
narrow bands: (1) The PP band includes all 3535 vHPCs that are
4–8 grid points from PV; (2) the PC band includes all 630 vHPCs
that are 0–6 grid points from the CV. The average number of
vHPCs per Lobule is 16 165, with Layer 1¼ 10 860, Layer 2¼ 4910,
and Layer 3¼ 720.
RESULTS
Histology
The histological evidence in Figures 3 and 4 is consistent with
that provided in earlier reports (Gujral et al., 2002). All 1 h sec-
tions were indistinguishable from control 0 h sections. Some
cells in the indicated area of the 2 h section in Figure 3 appear
somewhat swollen and pale. Examples of nucleus shrinkage in-
dicate that some hepatocytes are in various stages of pyknosis.
At 3 h, many hepatocytes close to CVs appear swollen, and they
are losing some basophilic staining. Closer to the CVs, there is
evidence of sparse necrosis. By 4.5 h, necrosis occurs, and the
area of necrosis is expanding. Pyknosis is more extensive than
at 3 h, and karyorrhexis (fragmentation and loss of nuclei) is ap-
parent (which is confirmed by results in Figure 4). By 6 h, karyor-
rhexis is widespread. There is further loss of basophilic
staining, and the areas of necrosis are expanding.
The TUNEL stained sections at 1, 2, and 3 h in Figure 4 reveal
no evidence of DNA fragmentation. However, by 4.5 h DNA frag-
mentation is evident in both the nucleus and the cytosol within
clearly defined regions close to the CVs. DNA breakage is a late
event in the molecular mechanisms of APAP hepatotoxicity.
Given the extent of DNA fragmentation at 4.5 h, as indicated by
extensive dark gray staining, the stained material is mostly
dead hepatocytes (maps to Necrotic). There is also evidence of
DNA fragmentation in several isolated hepatocytes close to the
area of extensive PC damage. At 6 h, the area of TUNEL staining
is enlarged.
Experiments Using Control Mice
Results of experiments using Control Mice are indistinguishable
from earlier results (reported by Smith et al., 2016, 2018). Below,
we summarize selected vAPAP disposition and toxicity meas-
urements at the vHPC level to facilitate comparisons with
results of experiments using Test Mice.
Results in Figure 5 show that per-vHPC values for vAPAP,
NAPQI, GSH Depletion events, Mitochondrial Damage, and
Damage Mitigation events within the PC band are larger than
corresponding average Lobular values. For NAPQI and
Mitochondrial Damage, they are dramatically larger. Lobular
values are larger than corresponding values within the PP band.
Those striking differences are a consequence of two factors: (1)
vHPCs are exposed to vAPAP sequentially, PP-to-PC; (2) the ma-
jority of Lobular vHPCs are in SS Layer 1.
The Lobular structure reflects the fact that compounds in
blood entering PV tracts get exposed to many more hepatocytes
than compounds in blood close to the CV. The Layer 1/Layer 3
vHPC ratio averages 15.1, with 65.9%, 29.8%, and 4.3% of vHPCs
in Layer 1, 2, and 3 SSes, respectively. Consequently, despite
vAPAP Metabolism in Layers 1 and 2, vAPAP per vHPC in Layer 3
is greater than in Layers 2 and 1. The ratio would be larger ex-
cept for a mitigating factor: as specified in Figure 2B, the proba-
bility of a vAPAP Metabolism event is Layer 3> Layer 2> Layer 1.
Those PP-to-PC differences help explain why per-vHPC amounts
for vAPAP within the PC band are >4 the amounts within the
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PP band (Figure 5A). Upstream Metabolism of vAPAP prevents
the difference from being larger.
Because NAPQI formation increases PP-to-PC (Figure 2B), the
per-vHPC amounts of NAPQI within the PC band (Figure 5C) are
larger than within the PP band. However, cumulative per-vHPC
GSH Depletion events within the PC band (Figure 5D) are only
about twice those within the PP band. That is in part a conse-
quence of the smaller PC GSH Depletion Threshold (Figure 2B).
The amounts of mitoD within the PP band are insignificant
compared with those within the PC band (Figure 5E) because of
the probability of a Damage Mitigation event (removal of a
mitoD) during each simulation cycle is largest within the PP
band (Figure 2B). Greater rates of Damage Mitigation within
the PP band limits mitoD accumulation and the cumulative
per-vHPC number of Damage Mitigation events within the PP
band (Figure 5F) demonstrates that the small amounts of
mitoD within PP vHPCs are a consequence of Damage
Mitigation, rather the absence of mitoD formation. That fea-
ture is consistent with in vivo studies demonstrating that mi-
tochondrial dysfunction is widespread and reversible after
APAP treatment (Hu et al., 2016). Besides, it has been shown
that extensive mitochondrial biogenesis outside the core area
of necrosis limits further expansion of the damaged area (Du
et al., 2017).
The mean distance from the CVs of Necrosis-Triggered
events (Figure 5B) is provided for only 80 min because we are
most interested in relative locations of early events. Because of
the considerable variance in locations of individual events, the
plotted average locations are 181-point moving averages. Figure
5B shows that the average location of Necrosis-Triggered events
in Control Mice begins close to but not at the CVs. The average
location corresponds to the highest density of Necrosis-
Triggered events averaged over many Monte Carlo trials.
Density values, which are highly skewed, diminish in the PP di-
rection. There is no clear demarcation between vHPCs that are
and those that are not Necrosis-Triggered. Whereas, clear
changes in staining pattern are evident at 3, 4.5, and 6 h in
Figure 3 and at 4.5 and 6 h in Figure 4.
A Refinement of the Control Mechanism
We experimented to test the hypothesis that relative to results
from experiments using Control Mice, requiring that the GSH
Depletion Threshold be breached before mitoD amplification
can occur will skew the mean location of early Necrosis-
Figure 3. Evidence of pericentral (PC) APAP-induced tissue injury. Shown are representative photomicrographs of liver sections stained with hematoxylin and eosin
(H&E) at the indicated times following a 300 mg/kg dose of APAP. The magnification of the 2 h section is 200; the magnification of the other sections is 100. Features
in the 1 h section are indistinguishable from those in the 0 h section.
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Triggered events toward the CV before spreading in the PP direc-
tion. The Mechanism refinement is presented in
Supplementary Experiment 7, and results supporting the hy-
pothesis are presented in Supplementary Figure 8. The refine-
ment caused the mean location of all early Necrosis-Triggered
events to shift dramatically closer to the CV, and the variance in
location of mean Necrosis-Triggered events was reduced con-
siderably. However, there is still no clear demarcation between
vHPCs that are and those that are not Necrosis-Triggered.
Test Mice: Logic Development Workflow
The logic diagram in Figure 6 is the end product of the following
workflow. We posited that 5 new behaviors would be needed to
achieve our objective. (1) Initiation of Necrosis-Triggered does
not occur in isolation. (2) Accumulate mitoD Damage Products
beyond some threshold value would be insufficient to initiate
Necrosis-Triggered; at least one downstream neighbor must
have also initiated Necrosis-Triggered. (3) One or more behav-
iors of vHPCs adjacent to the CV must be unique. (4) To enable
the first two behaviors in Test Mice, we changed Necrosis-
Triggered status (Control Mice) to Stressed state and Necrosis
Threshold to Stress Threshold. (5) In Control vHPCs, when
Necrosis Threshold is breached, there is an irreversible transi-
tion to Necrosis-Triggered. However, the transition to Stressed
should not be irreversible: while Stressed, if mitoD drops below
Stress Threshold during a simulation cycle, the vHPC reverts to
Normal status.
We began by addressing the first of the above four behaviors.
At the conclusion of a Control Mouse experiment (after all
NAPQI has been removed), we often see Necrotic vHPCs in Layer
3 that are surrounded by Normal vHPCs. We occasionally see a
Necrotic vHPC where the closest Necrotic neighbor is more than
two grid points distant. Moreover, we see some Normal vHPCs
adjacent and close to the CVs. The following is one of several
possible explanations for the latter: because of the stochastic,
discrete event nature of the simulations, early accumulation of
mitoD within those Normal vHPCs may have been insufficient
to breach the Necrosis Threshold. Analogous circumstances
may occur in vivo, but we see no histological evidence of one or
a few normal hepatocytes surrounded by damaged or necrotic
neighbors. We conjectured that having damaged or necrotic
neighbors may be sufficient to trigger necrosis. To avoid iso-
lated Necrotic vHPCs, we added this rule: if the vHPC has not
initiated Necrosis-Triggered, but its von Neumann neighbor-
hood (for Manhattan radius of r¼ 2; illustrated in Figure 6) con-
tains two or more downstream neighbors that have initiated
Necrosis-Triggered, then it initiates Necrosis-Triggered.
Subsequently, we added the option for the vHPC to use the
Figure 4. TUNEL staining for visualization of DNA fragmentation. These representative photomicrographs are mouse liver sections from the same experiment as the
Figure 3 liver sections. The magnification of all sections is 100. TUNEL positive cells are dark gray. The 1, 2, and 3 h sections show no evidence of TUNEL staining.
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r¼ 2 Moore neighborhood, because it increased the probability
that the vHPC will be influenced by a downstream neighbor
that has initiated Necrosis-Triggered. Using that rule caused
the average location of Necrosis-Triggered to be further
skewed in the CV direction relative to the corresponding
Control average locations. However, we observed several early
Necrosis-Triggered events at locations more than 5 grid points
from the CV, and much later Necrosis-Triggered events adja-
cent to CV.
Further, as trials progressed, we observed non-Necrosis-
Triggered vHPCs forming columnar features “Rising” from the
CV. The logic diagram for the preceding implementation, along
with revised diagrams for subsequent implementations, are
provided in Supplementary Figure 1. Depending on the trial,
von Neumann or Moore neighborhoods were used. Von
Neumann neighborhoods rely on an interface between vHPCs.
For example, a von Neumann neighborhood specified by r¼ 1,
encompasses only 4 vHPCs. With r¼ 2, the neighborhood
increases to 12. Moore neighborhoods do not require interfaces.
They include all vHPCs surrounding the decision-making vHPC.
A Moore neighborhood with r¼ 1 includes 8 neighbors; with
r¼ 2, the neighborhood extends radially: there are 24 neighbors.
In an effort to eliminate isolated Normal vHPCs and reduce
the nonbiomimetic columnar features, we extended the pre-
ceding explorations using r¼ 2 neighborhoods by adding a re-
quirement that 2 (and subsequently 4) lateral neighbors must
have initiated Necrosis-Triggered. Doing so reduced the co-
lumnar features and further skewed the average location of
Necrosis-Triggered events toward the CV, but also reduced
the total number of Necrosis-Triggered and Necrotic events.
The patterns caused us to question a specification carried for-
ward from much earlier work: vHPCs occupy only 90% of grid
points. During earlier work, we had envisioned placing other
Cell types on the vacant grid points. Adding vHPCs to all grid
points increased number of early Necrosis-Triggered events
and subsequent Necrotic events. Moore neighborhoods had
more Necrosis-Triggered events at later times adjacent to the
CV. The change also reduced differences in outcomes when
using the larger r¼ 2 neighborhoods versus r¼ 1 neighbor-
hoods. Because of the increased outcome similarity, we fo-
cused more on the smaller r¼ 1 neighborhood. Also, instead of
requiring downstream and lateral Necrosis-Triggered neigh-
bors, we relaxed the requirement to one or the other. Those
refinements produced further incremental progress toward
the objective.
We implemented the PC snapshot animations in part to help
generate ideas for further improvements. Upon inspection of
the first batch, we observed the emergence of a nonbiomimetic
Necrotic “V” pattern: more Necrotic vHPCs were consistently
piling-up at the lateral edges of the 2D SS snapshot grid. We hy-
pothesized that delivery of vAPAP from upstream SSes to the
leading grid points in each Layer 3 SS (top row in PC anima-
tions) was not random. We overcame that bias by rewriting
the tryRim() method in SS.java to eliminate any delivery bias.
Initial snapshots also showed that there were more Necrotic
events than Necrosis-Triggered events. The cause was a cod-
ing error. The error was corrected and cycling through the IR
Protocol continued. We explored reducing the number require-
ment for lateral and/or downstream neighbors. For some
experiments, reductions did not significantly alter temporal
patterns.
Experiments Using Test Mice
Recorded measurements are from experiments on two variants
of Test Mice, both employing the logic in Figure 6. One employs
the von Neumann neighborhood; the other employs the Moore
Figure 5. Control Mice: spatiotemporal measurements of intra-vHPC events. Control vHPCs do not communicate. Plotted values in A, B, C, and E are 181-point centered
moving averages. A, Values are average amounts of APAP in 1000 vHPCs. Lobule: Lobule-wide averages; PC: average amounts per vHPC in the first six grid spaces
adjacent to the CV; and PP: average amounts per vHPC in the 5th-9th grid spaces downstream of the PV entrance. B, Average location each simulation cycle of vHPCs
that have initiated Necrosis-Triggered. The gray-shaded area spans 6 1SD at 2.5–5 min intervals. C, Average amounts of NAPQI in 1000 vHPCs for the preceding three
locations. D, Total GSH Depletion events per vHPC. E, Average amounts of Mitochondrial Damage in 100 vHPC. F, Total Damage Mitigation (Repair) events per vHPC. For
cumulative profiles such as D and F, a repeat experiment would not generate the exact same values.
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neighborhood. Their Figure 2C model mechanisms use identical
specifications. Consequently, measurements of many vAPAP
Disposition, Metabolism, and Toxicity features during these two
experiments along with those from Control Mouse experiments
were indistinguishable because entities and events preceding
breaching the Necrosis Threshold (Control experiments) or
Stressed Threshold (Test experiments) are the same. An exam-
ple is the amount of vAPAP in Mouse Body (maps quantitatively
to APAP blood levels in mice) in Figure 7A. The data are from the
experiment on Test Mice employing von Neumann-based logic.
At the resolution of the data, vAPAP measurements from Test
Mice using Moore-based logic and from Control Mice are
indistinguishable (superimposable). Location-dependent per-
vHPC amounts of vAPAP, NAPQI, and cumulative GSH Depletion
(as in Figure 5) from experiments on Controls and Test Mice
were comparable.
Figure 6 logic employed by Test Mice specifies that to initiate
Necrosis-Triggered, a Stressed vHPC must be either adjacent to
CV or have one downstream neighbor that has initiated
Necrosis-Triggered. A Normal vHPC must initiate Necrosis-
Triggered when its two lateral neighbors have initiated
Necrosis-Triggered.
The following is an example of a sequence of events that can
occur. (1) At the end of simulation cycle t, a vHPC is Stressed. It
Figure 6. Logic used each simulation cycle by Test Mouse vHPCs to decide to initiate (or not) Necrosis-Triggered. Whether a vHPC is Stressed mediates the logic. After
initiating Necrosis-Triggered, the vHPC schedules transition-to-Necrotic to occur following a randomly specified delay. Moore and von Neumann neighborhoods are il-
lustrated relative to the center decision-making vHPC. Darker vHPCs: neighborhood with a r ¼ 1 Manhattan radius; darker þ lighter vHPCs: neighborhood with a r ¼ 2
Manhattan radius. For the results in Figures 7 and 8, n ¼ 2, m ¼1, and r ¼ 1.
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has one adjacent lateral neighbor that is Necrosis-Triggered
(but no downstream neighbor is Necrosis-Triggered). (2) At the
end of simulation cycle tþ 1, because its mitoD count has
dropped, it has reverted to Normal. Also, during simulation cy-
cle tþ 1, a second lateral neighbor has initiated Necrosis-
Triggered. (3) Although the vHPC is Normal, during simulation
cycle tþ 2, it initiates Necrosis-Triggered.
The moving averages for the mean location of Stressed
events (Figure 7B) are necessarily similar to the corresponding
distance-from-CV measurements for Necrosis-Triggered in
Figure 5B. That is because the criterion for initiating Stressed
and Necrosis-Triggered are the same. We observed no signifi-
cant difference between cumulative Stressed events for Test
Mice using von Neumann- and Moore-based logic (Figure 7C).
The significant difference in per-vHPC cumulative number of
Stressed events within PC and PP bands is a consequence of dra-
matic differences in per-vHPC mitoD amounts; see Figure 5E.
Per-vHPC mitoD amounts are mostly the same for Test and
Control Mice.
There are sharp differences between moving averages for
the mean distance from the CV of Necrosis-Triggered events in
Test (Figure 7D) and Control Mice (Figure 5B). In Test Mice, those
averages start at the CV and stay tightly clustered as the loca-
tion advances upstream from the CV. The phenomenon is illus-
trated in Figure 8 and Supplementary Videos 2–6. The
cumulative numbers of Necrosis-Triggered events (Figure 7E)
for both Test Mice are virtually indistinguishable. It is notewor-
thy that those values are dramatically smaller than
corresponding Control Mice values. In Control Mice, some
Necrosis is triggered considerably upstream of the CV. At 6 h
during each trial, several vHPCs in Lobular Layer 2, along with
fewer in Layer 1, have initiated Necrosis-Triggered. In experi-
ments on Test Mice (for the Dose used), there were no Necrosis-
Triggered events in Layers 1 and 2.
At the resolution of the Damage Mitigation event data
(Figure 7F), measurements from Test Mice using von Neumann-
and Moore-based logic are indistinguishable, which is evidence
that the logic used has no cumulative influence on other Figure
2C events.
Pericentral Snapshot Animations
Figure 8 presents a sequence of images from Supplementary
Video 2 recorded from one Layer-3 SS during one trial of a 12-
trial experiment. The images convey a reasonable impression of
how events unfolded during an experiment that employs von
Neumann-based logic. After 6 h, all vHPCs adjacent to CVs were
Necrotic in all 12 trials. Eight snapshots show no Stressed
vHPCs. It may seem surprising that Stressed vHPCs are so
sparse. However, during the illustrated experiment, 25 999 vHPC
entered Stressed status. Because mitoD is being generated and
depleted (by Damage Mitigation) before depletion of vAPAP, it is
possible for a vHPC to transition from Normal to Stressed to
Normal more than once. Note the Stressed vHPC at 1.92 h. There
is a Necrosis-Triggered vHPC downstream, but because this Test
Mouse is employing von Neumann-based logic, it does not initi-
ate Necrosis-Triggered. Had this arrangement occurred during
Figure 7. Test Mice: spatiotemporal measurements of intra-vHPC events. Each vHPC utilizes information acquired from neighbors in following the logic in Figure 6
with n ¼ 2 and m ¼ 1. Results are from two independent experiments, during which only the r ¼ 1 neighborhoods in Figure 6 are used. Experiment 1: each vHPC
acquires information from neighbors within its von Neumann (VN) neighborhood. Experiment 2: each vHPC acquires information from neighbors within its Moore
(MO) neighborhood. Distances from CV for Stressed and Necrosis-Triggered events are 181-point centered moving averages. A, APAP amounts in Mouse Body from
Experiment 1. Results from Experiment 2 are identical. B, Average location of Stressed vHPCs each simulation cycle. C, Cumulative Stressed events per vHPC from
Experiment 2. Lobule, PP, and PC are as specified in Figure 5. At this resolution, Lobule and PP data from Experiment 2 are indistinguishable. D, Average location each
simulation cycle of vHPCs that have initiated Necrosis-Triggered. Necrosis-Triggered always occurs first in vHPCs adjacent to the CV (see Supplementary Videos S2-S6).
The gray-shaded area spans 6 1SD (at 2.5–5 min intervals) for the von Neumann neighborhood in Experiment 1. E, Cumulative Necrosis-Triggered events per 100
vHPCs. Corresponding data from Control vHPCs are provided for comparison. Because many Stressed vHPCs did not meet the logic conditions during Test Mouse
experiments, cumulative Necrosis-Triggered events during the latter are only about 29% of those that occurred during the Control Mouse experiment. F, Cumulative
Damage mitigation events from Experiment 1. At this resolution, corresponding data from Experiment 2 is indistinguishable.
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the Test Mouse experiment that employed Moore-based logic,
that vHPC would have initiated Necrosis-Triggered. Even
though this is only a single illustration, one might expect that
the Test Mouse experiment employing Moore-based logic could
generate more Necrotic events. That is indeed the case: cumula-
tive Necrotic events¼ 4764 for the Figure 8 experiment, which
employed von Neumann-based logic, whereas cumulative
Necrotic events¼ 5449 for the experiment that employed
Moore-based logic.
DISCUSSION
The mechanisms utilized by Control Mice (Figs. 2A and 2B) pro-
vide a plausible, somewhat coarse grain model of explanation
for selected early features of APAP-induced hepatic injury.
Other well-documented features and phenomena that become
evident after 6 h are not yet addressed. Examples include in-
volvement of the immune system, early disruption of cell-cell
tight junctions, mitochondrial autophagy and biogenesis, re-
moval of APAP protein adducts, and hepatocyte proliferation.
Control vHPCs function independent of their neighbors.
Because of built-in stochasticity, the average location of
Necrosis-Triggered events (gray area, Figure 5B) can shift within
and between trials. Consequently, at any time post-Dose, there
is no clear demarcation between Necrosis-Triggered vHPCs and
vHPCs designated Normal in Figure 2A. The absence of a clear
transition is inconsistent with patterns of damage evidenced by
the H&E staining (Figure 3) and TUNEL labeling (Figure 4).
By imposing the following two additional target attributes,
the Control mechanism from Smith et al. (2018) was falsified. (1)
The earliest Necrosis-Triggered events occur first adjacent to
the CV, and (2) subsequent Necrosis-Triggered events occur pri-
marily adjacent to vHPCs that have already Triggered Necrosis.
To achieve those targets, we employed two divergent
approaches. The first maintains quasi-autonomous vHPC func-
tion; therefore, requiring no inter-vHPC communication. There
are multiple ways in which the quasi-autonomous Control
mechanism might be refined as part of a strategy to achieve
both new targeted attributes. We considered several refine-
ments and discovered that coupling mitoD amplification to the
breaching of the GSH Depletion Threshold moved average early
Necrosis-Triggered events closer to CV (Supplementary
Experiment 7), but did not cause them to start near the CV.
However, a sizable space of candidate model mechanisms
remains, in which quasi-autonomous vHPC function is main-
tained and inter-vHPC communication is not essential, that
may achieve the two target attributes within some tolerance.
An exploratory tuneable resolution approach (Kirschner et al.,
2014) can be used to extend the preceding feature coupling strat-
egy to include couplings among additional Figure 2A events,
particularly couplings that include Damage Mitigation. Doing so
may require synchronizing Lobular location-dependent configu-
rations beyond the five in Figure 2B. However, before proceed-
ing, we must shrink considerably the space of candidate
mechanism variants that will be explored. The process of elimi-
nating model mechanisms will require wet-lab evidence capable
of eliminating (falsifying) some variants but not others. One
source of such evidence could be multiple same-time, same-
liver histological sections in which CV-to-PV patterns (or lack
thereof) of different relevant macromolecular targets are visual-
ized using immunohistochemical staining methods. Another
source of evidence might come from necessary improvements
in one or more of these three advanced technologies: (1) Using
matrix-assisted laser desorption/ionization mass spectrometry
imaging (MALDI MSI) to obtain spatiotemporal visualizations of
the intrahepatic distribution of selected macromolecules, as
done recently with APAP metabolites and protein adducts
(Sezgin et al., 2018). (2) Resolving intralobular coordinates for
specific sets of liver genes based on zonation of landmark genes
(Halpern et al., 2017). (3) Classifying relative expression levels of
selected macromolecules in PP and PC lobular sections obtained
by laser microdissection, as done by Tachikawa et al. (2018) for
drug transporters and metabolizing enzymes.
Ample wet-lab evidence supports the pursuit of Control
mechanism modifications that use an analogy of intracellular
communication to achieve the two target attributes.
Communication through gap junctions is the most straightfor-
ward and direct (Asamoto et al., 2004). Evidence suggests that it
can facilitate and counteract hepatic cell death processes
(Decrock et al., 2009). APAP-induced necrosis is modulated by at-
tached cells via gap junctions (Saito et al., 2014). Maes et al.
(2017) report that blocking connexin hemichannels reduces
Figure 8. Representative snapshots taken during a single Test Mouse trial. The value on each image is the time (hours) after Dosing when each image was recorded.
Data were recorded from one of the three Layer 3 SSes during a single Test Mouse trial. The black-bordered vHPC (often isolated) are Stressed. Light shaded vHPCs are
Necrosis-Triggered. Black vHPCs are Necrotic.
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measurements of APAP-induced toxicity. On the other hand, ge-
netic ablation of connexin32 does not alter the characteristic
features of APAP hepatotoxicity (Maes et al., 2016).
The evidence supporting interhepatocyte exosome-based
communication is stronger. Exosomes function within various
tissues as intercellular communication vehicles. They deliver a
variety of signaling macromolecules between particular cells to
modulate or mediate cellular processes (Hirsova et al., 2016; Lai
et al., 2015; Tetta et al., 2013). The following are relevant exam-
ples. Stress-induced changes in exosome composition can influ-
ence the responses of distant cells (Villarroya-Beltri et al., 2014).
Exosomes alter the behavior of recipient cells (Lemoinne et al.,
2014; Tetta et al., 2013). Within hepatic lobules, exosomes medi-
ate intercellular communication in diseases (Szabo and
Momen-Heravi, 2017), and exosome alterations contribute to
the pathogenesis of drug-induced liver injury (Holman et al.,
2016; Thacker et al., 2018). Changes in exosome content precede
hepatocyte necrosis caused by tolvaptan (Mosedale et al., 2018).
Significant alterations in hepatocyte-derived exosome produc-
tion (Duan et al., 2019) and content (Holman et al., 2016) have
been reported following subtoxic APAP exposure in vivo and
in vitro (Holman et al., 2016). Exosomes from mice with acute
APAP-induced liver injury initiate hepatocyte injury in healthy
recipient mice (Cho et al., 2018).
We conjecture that the variety of macromolecules carried by
hepatocyte-derived exosomes during the processes illustrated
in Figure 9A provides information that influences the recipient
hepatocyte’s processes causing the emergence of necrotic pat-
terns, eg, those in Figures 3 and 4. A requisite for generating an
analogous phenomenon within Test Mice is that each vHPC has
ongoing access to information about changes in the status of its
neighbor vHPCs during Stage 1 (Figure 9B). We implemented
means for vHPCs to acquire the information during each cycle.
Stage 2 is the mandatory transition from Necrosis-Triggered to
Necrotic following a Monte Carlo-sampled time lag.
In Control Mice, vHPCs are either Normal, Necrosis-
Triggered, or Necrotic (Figure 2A). During early explorations, we
realized we needed a Stressed status (Figure 2C) and that a
Stressed vHPC would need to use neighbor status information
when considering whether it will initiate Necrosis-Triggered.
After exploring several different rule combinations and
information-use options (Supplementary Figure 1), we con-
cluded that it would also be necessary to require that a non-
Stressed vHPC initiate Necrosis-Triggered when it is flanked by
n¼ 2 vHPCs that have already initiated Necrosis-Triggered.
When vHPCs execute the resulting mechanism (Figure 2C) and
apply the logic in Figure 6 within the two-stage process (Figure
9B), the evidence in Figures 7, 8, and Supplementary Videos 2–6
shows that Necrosis-Triggered events always occur first adja-
cent to the CV and then spread periportally adjacent to vHPCs
that have already initiated Necrosis-Triggered. A consequence
is that the variance in location of Necrosis-Triggered events is
reduced sufficiently (the gray area in Figure 7D compared with
the gray area in Figure 5B) to make clearly evident when and
where the transition from Stage 1 to Stage 2 vHPCs occurs.
Although no wet-lab evidence is specifically supportive at
comparable levels of granularity, we hypothesize that the two-
stage process depicted in Figure 9B is strongly analogous to the
actual progression of APAP-induced hepatic injury illustrated in
Figure 9A. It can stand as a plausible explanatory theory until
contradictory wet-lab evidence is published. However, becom-
ing Necrosis-Triggered (and subsequently Necrotic) is not a
seamless continuation of an unfolding model mechanism.
Instead, the transition is a product of applying the logic in
Figure 6, and that logic is a placeholder for a yet-to-be-posited,
concrete virtual communication mechanism.
Figure 9. The progression of features characterizing APAP-induced hepatic injury. A, This spectrum depicts APAP-induced hepatic injury in vivo as a complex process.
Stages of progression are typically identified by a characteristic feature or activity, including those listed. B, This sketch depicts simulated APAP-induced injury in Test
Mice as a two-stage sequence. Stage 1 (Normal-to-Stressed) is the coarse grain biomimetic model mechanism described in Figure 2C. During Stage 2, each vHPC deter-
mines its ultimate fate by using acquired information about neighbor status and adhering to Figure 6 logic.
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The model mechanism utilized by Test Mice and the one
above (Supplementary Experiment 7), which strove to achieve
the two new target attributes by making intra-vHPC events cou-
pled and incrementally more interconnected and detailed, are
presented as being divergent approaches. Reality may map to a
convergence of those mechanisms in which a primary role of
interhepatocyte communication is to tightly coordinate and
maintain hepatocyte processes based in part on relative PV-to-
CV location, thereby minimizing the variance of hepatotoxicity
attributes of collocated hepatocytes.
Direct validation evidence is needed to strengthen the credi-
bility for a more explanatory communication-enabled model
mechanism. A logical next step in acquiring that evidence is to
develop an alternative to the Test Mouse mechanism in Figure
2C in which each individual vHPC generates and exports con-
crete objects that contain necessary information on its current
status—call it vMouse-2. Neighboring vHPCs would be able to
recognize those objects, distinguish them from other mobile
objects, such as vAPAP and its Metabolites, internalize them (or
not) and the contained information would (or not) influence on-
going processes. The objects generated by a vMouse-2 mecha-
nism would be intentionally analogous to exosomes. A vMouse-
2 mechanism could be discovered and developed scientifically
using cross-model validation, with Test Mouse phenomena as
referents. Quantitative validation targets for use during IR
Protocol cycles would come from measurements of Test Mouse
phenomena, such as those in Figures 7 and 8. Once cross-model
validation targets are achieved, efforts can begin to establish
mappings between the dynamics of virtual exosomes along
with the information that they contain, and (1) direct quantita-
tive measurements of exosomes, (2) the molecular signals con-
tained in those exosomes, and (3) the intracellular pathways
that those signals influence.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences
online.
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